All press releases
Company News

Strategic Partnership with ACTA Lab

Announcing our collaboration with ACTA Lab to advance medical-imaging AI through shared infrastructure, datasets, and peer-reviewed research.

Strategic Partnership with ACTA Lab

BioAnalytiX is excited to announce a strategic partnership with ACTA Lab, a leading research institution in medical imaging and artificial intelligence. This collaboration marks a pivotal step in advancing our AI-powered diagnostic solutions.

Partnership Objectives

Through this partnership, we aim to:

  • Share cutting-edge research infrastructure and computational resources
  • Collaborate on peer-reviewed research publications
  • Access diverse medical imaging datasets for algorithm training
  • Accelerate the development and validation of our AI models

Advancing Medical AI Research

ACTA Lab brings years of expertise in medical imaging and machine learning research. Their advanced facilities and research methodologies will enable us to refine our algorithms and expand our diagnostic capabilities beyond brain imaging.

Impact on Healthcare

This partnership will accelerate the development of more robust, clinically validated AI solutions that healthcare professionals can trust. By combining academic rigor with entrepreneurial innovation, we're working to bridge the gap between research and real-world clinical applications.

Commitment to Scientific Excellence

We remain committed to evidence-based development, ensuring our solutions meet the highest standards of medical accuracy and reliability. This partnership reinforces our dedication to scientific excellence and responsible AI development in healthcare.

Ready to bring AI-assisted diagnostics to your team?

Request beta access to Orasis AI and see how BioAnalytiX helps radiologists detect anomalies faster and with greater accuracy.